Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!

Cadila Healthcare shares up 3% on plans to launch COVID-19 vaccine by March 2021

Zydus Cadila said it will apply for Phase 3 clinical trials of its experimental COVID-19 vaccine in December, and expects to launch it by March 2021.

November 27, 2020 / 09:34 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Cadila Healthcare share price jumped over 3 percent in the morning session on November 27 after Zydus Cadila said it will apply for Phase 3 clinical trials of its experimental COVID-19 vaccine in December and expects to launch it by March 2021.

"If all goes well, the company expects to introduce the vaccine by March next year," a source told The Economic Times.

Moneycontrol could not independently verify the story.

Zydus Cadila will submit results of the Phase 2 trials next week, which "will ascertain the safety, dose and efficacy of the potential vaccine", a source said.

Initial results from the Phase 2 trials indicate that ZyCoV-D, the company's vaccine candidate, that no safety concerns were observed, the report said. According to the report, the company is looking to conduct Phase 3 trials of the vaccine against COVID-19 on 39,000 participants.

Close

"We could be looking at manufacturing 100 million doses to begin with, once the vaccine receives all regulatory permissions," Zydus Cadila Chairman Pankaj R Patel recently told The Economic Times.

The stock was trading at Rs 436.80, up Rs 14.45, or 3.42 percent at 09:23 hours. It has touched an intraday high of Rs 441.75 and an intraday low of Rs 434.50.
Moneycontrol News
first published: Nov 27, 2020 09:34 am

stay updated

Get Daily News on your Browser
Sections